Chennai, December 7, 2008 Vaso Meditech, the exclusive distributor and clinical support provider for Vasomedical EECP in India, proudly announced the presentation of clinical benefits of EECP therapy in patients with Left Ventricular Dysfunction at the 60th Annual Conference of the Cardiology Society of India held in Chennai. The presentations were delivered by two leading cardiac institutions in Chennai, Frontier Lifeline Hospital and Dr. K.M. Cherian Heart Foundation along with Harvey Hospitals, highlighting the growing success of EECP as a non invasive treatment option for advanced cardiac conditions. The studies demonstrated significant improvement in cardiac function, exercise tolerance, and quality of life among patients undergoing EECP therapy. Medical experts at the conference discussed how EECP is increasingly recognized as an effective alternative heart treatment for patients who are not suitable for bypass surgery or angioplasty. The event also reinforced the reputation of Chennai as a destination for advanced non invasive cardiac care, with several hospitals emerging as a best EECP center for patients seeking safe and proven therapy for chronic heart disease and left ventricular dysfunction. Vaso Meditech continues to support the advancement of EECP technology and awareness among cardiologists and healthcare providers across India.
EECP THERAPY uses a proprietary technology to inflate and deflate a series of pneumatic cuffs enclosing the lower extremities of the patients. Treatment is administered on a padded table in which three sets of electronically controlled inflation and deflation valves are located.
